Search Results - "Boutarfa, Asma"

A label‐free impedance assay in endothelial cells differentiates the activation and desensitization properties of clinical S1P1 agonists by Grailhe, Patrick, Boutarfa‐Madec, Asma, Beauverger, Philippe, Janiak, Philip, Parkar, Ashfaq A.

“…S1P1 activation maintains endothelial barrier integrity, whereas its desensitization induces lymphopenia. SAR247799, a new G protein‐biased S1P1 agonist, was…”
Get full text

A label-free impedance assay in endothelial cells differentiates the activation and desensitization properties of clinical S1P 1 agonists by Grailhe, Patrick, Boutarfa-Madec, Asma, Beauverger, Philippe, Janiak, Philip, Parkar, Ashfaq A

“…Sphingosine-1 phosphate receptor-1 (S1P ) activation maintains endothelial barrier integrity, whereas S1P desensitization induces peripheral blood lymphopenia…”
Get full text

Immunosuppressive effects of mesenchymal stem cells : Involvement of HLA-G by NASEF, Aisha, MATHIEU, Noelle, FOUILLARD, Loïc, CHAPEL, Alain, PRICK, Johanna, FRANCOIS, Sabine, MAZURIER, Christelle, BOUTARFA, Asma, BOUCHET, Sandrine, GORIN, N-Claude, THIERRY, Dominique

“…Mesenchymal stem cells (MSCs) possess unique immunomodulatory properties. They are able to suppress allogenic T-cell response and modify maturation of…”
Get full text

Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model by François, Sabine, Mouiseddine, Moubarak, Mathieu, Noëlle, Semont, Alexandra, Monti, Pascale, Dudoignon, Nicolas, Saché, Amandine, Boutarfa, Asma, Thierry, Dominique, Gourmelon, Patrick, Chapel, Alain

“…It has been suggested that human mesenchymal stem cells (hMSC) could be used to repair numerous injured tissues. We have studied the potential use of hMSC to…”
Get full text

Discovery of SAR184841, a potent and long-lasting inhibitor of 11β-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D by Venier, Olivier, Pascal, Cécile, Braun, Alain, Namane, Claudie, Mougenot, Patrick, Crespin, Olivier, Pacquet, François, Mougenot, Cécile, Monseau, Catherine, Onofri, Bénédicte, Dadji-Faïhun, Rommel, Leger, Céline, Ben-Hassine, Majdi, Van-Pham, Thao, Ragot, Jean-Luc, Philippo, Christophe, Farjot, Géraldine, Noah, Lionel, Maniani, Karima, Boutarfa, Asma, Nicolaï, Eric, Guillot, Etienne, Pruniaux, Marie-Pierre, Güssregen, Stefan, Engel, Christian, Coutant, Anne-Laure, de Miguel, Beatriz, Castro, Antonio

“…Starting from 11β-HSD1 inhibitors that were active ex vivo but with Cyp 3A4 liability, we obtained a new series of adamantane ureas displaying potent…”
Get full text

Discovery of SAR184841, a potent and long-lasting inhibitor of 11[beta]-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D by Venier, Olivier, Pascal, Cecile, Braun, Alain, Namane, Claudie, Mougenot, Patrick, Crespin, Olivier, Pacquet, Francois, Mougenot, Cecile, Monseau, Catherine, Onofri, Benedicte, Dadji-Faiehun, Rommel, Leger, Celine, Ben-Hassine, Majdi, Van-Pham, Thao, Ragot, Jean-Luc, Philippo, Christophe, Farjot, Geraldine, Noah, Lionel, Maniani, Karima, Boutarfa, Asma, Nicolaie, Eric, Guillot, Etienne, Pruniaux, Marie-Pierre, Guessregen, Stefan, Engel, Christian, Coutant, Anne-Laure, de Miguel, Beatriz, Castro, Antonio

“…Starting from 11[beta]-HSD1 inhibitors that were active ex vivo but with Cyp 3A4 liability, we obtained a new series of adamantane ureas displaying potent…”
Get full text